GENI vs GRPN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

GENI

50.1
AI Score
VS
GENI Wins

GRPN

46.5
AI Score

Investment Advisor Scores

GENI

50score
Recommendation
HOLD

GRPN

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GENI GRPN Winner
Revenue 669.49M 498.42M GENI
Net Income -111.58M -83.25M GRPN
Gross Margin 23.0% 90.8% GRPN
Net Margin -16.7% -16.7% GRPN
Operating Income -151.33M 23.64M GRPN
ROE -15.4% 195.6% GRPN
ROA -9.9% -12.4% GENI
Total Assets 1.13B 670.41M GENI
Cash 280.56M 296.08M GRPN
Current Ratio 1.56 0.98 GENI
Free Cash Flow 64.54M 49.87M GENI

Relative Price Performance (Last 90 Days)

GENI 1M: -10.8% · 3M: -3.0% GRPN 1M: -15.4% · 3M: +11.0%

Current Technical Phase

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.8 · Price: $6.82

GRPN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.1 · Price: $18.73

Fundamentals Snapshot

Metric GENI GRPN
Market Cap
Forward P/E 6.4 21.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.6% 0.0%
Gross Margin 0.3% 0.9%
Operating Margin -0.1% 0.0%
EPS -0.64 -3.13
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.